The Use of the Pulmonary Function Laboratory in Diagnosing Asthma
This chapter aims to provide the general clinician with a good understanding of available tests in the pulmonary function laboratory to help characterize asthma. It focuses on how tests are defined and performed, their limitations, their interpretations, and how to use them to follow asthma over time. Bronchoprovocation testing is also discussed, and utilization of arterial blood gas tests to help make acute triage decisions is reviewed. The key elements pertinent to each topic are listed in the “Key Points” at the beginning of this chapter.
KeywordsChronic Obstructive Pulmonary Disease Lung Volume Forced Vital Capacity Functional Residual Capacity Obstructive Lung Disease
The authors wish to thank Richard E. Kanner, MD, and Theodore G. Liou, MD, authors of the prior edition of this chapter, for laying the groundwork from which we could write this edition.
- 1.Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948–968.PubMedCrossRefGoogle Scholar
- 2.National Heart Lung, and Blood Institute. Expert panel report 3: Guidelines for the diagnosis and management of asthma – full report 2007. wwwnhlbinihgov/guidelines/asthma. August 28, 2007.Google Scholar
- 5.Simon MR, Chinchilli VM, Phillips BR, Sorkness CA, Lemanske RF, Jr., Szefler SJ, Taussig L, Bacharier LB, Morgan W. Forced expiratory flow between 25% and 75% of vital capacity and FEV1/forced vital capacity ratio in relation to clinical and physiological parameters in asthmatic children with normal FEV1 values. J Allergy Clin Immunol 2010;126:527–534 e521-528.Google Scholar
- 6.Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005;26:319–338.PubMedCrossRefGoogle Scholar
- 12.Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720–735.PubMedCrossRefGoogle Scholar
- 13.Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. General considerations for lung function testing. Eur Respir J 2005;26:153–161.PubMedCrossRefGoogle Scholar
- 14.Morris AH, Intermountain Thoracic Society. Clinical pulmonary function testing: A manual of uniform laboratory procedures. Salt Lake City, Utah: Intermountain Thoracic Society; 1984.Google Scholar
- 21.Global initiative of chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2009 update.: Published by Medical Communications Resources, Inc.; 2009.Google Scholar
- 24.Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS board of directors, July 1999. Am J Respir Crit Care Med 2000;161:309–329.PubMedGoogle Scholar
- 28.Foschino Barbaro MP, Lacedonia D, Palladino GP, Bergantino L, Ruggeri C, Martinelli D, Carpagnano GE. Dyspnea perception in asthma: Role of airways inflammation, age and emotional status. Respir Med 2010;105:195–203.Google Scholar